Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 21, Issue 12, Pages 1533-1545
Publisher
SAGE Publications
Online
2015-02-07
DOI
10.1177/1352458514567215
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunology of Relapse and Remission in Multiple Sclerosis
- (2014) Lawrence Steinman Annual Review of Immunology
- Peripheral T Cells Are the Therapeutic Targets of Glucocorticoids in Experimental Autoimmune Encephalomyelitis
- (2014) S. Wust et al. JOURNAL OF IMMUNOLOGY
- Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients
- (2013) Laura D. Serpero et al. Journal of Neuroimmune Pharmacology
- IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39
- (2013) Ivan D Mascanfroni et al. NATURE IMMUNOLOGY
- Self-tolerance in multiple sclerosis
- (2012) R. E. Gonsette ACTA NEUROLOGICA BELGICA
- Upregulation of IL-17, but not of IL-9, in circulating cells of CIS and relapsing MS patients. Impact of corticosteroid therapy on the cytokine network
- (2012) Nathalie Muls et al. JOURNAL OF NEUROIMMUNOLOGY
- Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations
- (2012) Petra Praksova et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis
- (2011) Ying Li et al. JOURNAL OF NEUROIMMUNOLOGY
- Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse
- (2011) Evelyn Peelen et al. JOURNAL OF NEUROIMMUNOLOGY
- T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients
- (2011) Dacia Dalla Libera et al. PLoS One
- Influence of Short-Term Glucocorticoid Therapy on Regulatory T Cells In Vivo
- (2011) Silviu Sbiera et al. PLoS One
- Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate
- (2010) Ye Zheng et al. NATURE
- Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell–like and Foxp3+ regulatory T cells
- (2010) Roopali Gandhi et al. NATURE IMMUNOLOGY
- The Inflammasomes: Guardians of the Body
- (2009) Fabio Martinon et al. Annual Review of Immunology
- Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery
- (2009) Anna Dodero et al. BLOOD
- Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
- (2009) Verena Brucklacher-Waldert et al. BRAIN
- CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
- (2009) J. M. Fletcher et al. JOURNAL OF IMMUNOLOGY
- Glucocorticoids increase CD4+CD25highcell percentage and Foxp3 expression in patients with multiple sclerosis
- (2008) M. Braitch et al. ACTA NEUROLOGICA SCANDINAVICA
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
- (2007) John S. Tzartos et al. AMERICAN JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search